Repositioning Candidate Details
| Candidate ID: | R1036 |
| Source ID: | DB06518 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | R-1487 |
| Synonyms: | -- |
| Molecular Formula: | C19H18F2N4O3 |
| SMILES: | CN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=C1N=C(NC1CCOCC1)N=C2 |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 449811-92-1 |
| Molecular Weight: | 388.368 |
| DrugBank Indication: | Investigated for use/treatment in rheumatoid arthritis. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | Mitogen-activated protein kinase 14 |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I15 | 1290 | Bone disease | A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function. http://en.wikipedia.org/wiki/Bone_disease | disease of anatomical entity/ musculoskeletal system disease/connective tissue disease | Details |